Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Liaoning Chengda CoSHSE:600739 -0.82%54 Days Payable is 24.42 as of Mar. 2026, which is 11% below its 10-year median of 27.51. GuruFocus rates SHSE:600739 with a GF Score™ of 54/100 and a GF Value™ of ¥9.70 (Modestly Overvalued). The stock has 6 warning signs investors should review. Among 115 Medical Distribution companies, Liaoning Chengda Co ranks worse than 94.78% on this metric.
The historical rank and industry rank for Liaoning Chengda Co's Days Payable or its related term are showing as below:
SHSE:600739'
s Days Payable Range Over the Past 10 Years
Min: 18.71 Med: 27.51 Max: 77.76
Current: 22.55
During the past 13 years, Liaoning Chengda Co's highest Days Payable was 77.76. The lowest was 18.71. And the median was 27.51.
SHSE:600739's Days Payable is ranked worse than 94.78% of 115
companies
in the Medical Distribution industry
Industry Median: 79.11
vs SHSE:600739: 22.55
Liaoning Chengda Co's Days Payable
declined
from Mar. 2025 (24.86) to Mar. 2026 (24.42).
It may suggest that Liaoning Chengda Coaccelerated paying its suppliers.
Liaoning Chengda Co Days Payable Related Terms
Liaoning Chengda Co Days Payable Historical Data
* Premium members only.
The historical data trend for Liaoning Chengda Co's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:600739 vs MCK, CAH, COR: Days Payable Comparison
For the Medical Distribution subindustry, Liaoning Chengda Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Liaoning Chengda Co Days Payable vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Liaoning Chengda Co's Days Payable distribution charts can be found below:
* The bar in red indicates where Liaoning Chengda Co's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Liaoning Chengda Co's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Liaoning Chengda Co (SHSE:600739) has a Days Payable of 24.42 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Liaoning Chengda Co and its competitors. This is 11% below median its historical median of 27.51. Over the past decade, Liaoning Chengda Co's Days Payable has ranged from 18.71 to 77.76. According to the industry distribution chart, Liaoning Chengda Co ranks #109 out of 115 companies in the Medical Distribution industry, placing it in the top 94.8%.
Is Liaoning Chengda Co's Days Payable too high?
Liaoning Chengda Co's current Days Payable of 24.42 is 11% below median its 10-year median of 27.51. Over the past 10 years, this metric has ranged from a low of 18.71 to a high of 77.76. The Medical Distribution industry median Days Payable is 79.11. Liaoning Chengda Co's value of 24.42 is 69.1% below this industry median. Based on the distribution chart, Liaoning Chengda Co ranks #109 out of 115 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, Liaoning Chengda Co has a GF Score™ of 54/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Liaoning Chengda Co's Days Payable compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Liaoning Chengda Co ranks #109 out of 115 companies for Days Payable. This places Liaoning Chengda Co in the lower half of its industry. The industry median Days Payable is 79.11. Liaoning Chengda Co's value of 24.42 is 69.1% below this benchmark. Historically, Liaoning Chengda Co's own Days Payable has ranged from 18.71 to 77.76 over the past decade. While the company's 10-year median is 27.51 vs. the industry median of 79.11, Liaoning Chengda Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Distribution company?
The median Days Payable among Medical Distribution companies is 79.11, based on 115 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Liaoning Chengda Co's current Days Payable of 24.42 is 69.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Liaoning Chengda Co and its competitors. For the Medical Distribution industry, the median Days Payable is 79.11 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Liaoning Chengda Co's current Days Payable is 24.42, which is 11% below median its own 10-year median of 27.51. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Liaoning Chengda Co stock overvalued right now?
Based on GuruFocus' analysis, Liaoning Chengda Co (SHSE:600739) is currently considered Modestly Overvalued. The stock's GF Value™ is ¥9.70, compared to a current price of ¥10.90 — trading 12.4% above its estimated fair value. The current Days Payable is 24.42, which is 11% below median its 10-year median of 27.51 and 69.1% below the Medical Distribution industry median of 79.11. Liaoning Chengda Co's overall GF Score™ is 54/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Liaoning Chengda Co (SHSE:600739), the current Days Payable is 24.42 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Liaoning Chengda Co (SHSE:600739) Overvalued in 2026?
Based on GuruFocus' analysis, Liaoning Chengda Co stock appears to be overvalued.
The current stock price of ¥10.90 is trading 12.4% above its estimated GF Value™ of ¥9.70.
GuruFocus considers Liaoning Chengda Co to be Modestly Overvalued.
Key valuation signals for SHSE:600739:
Days Payable: 24.42 (11% below median its 10-year median of 27.51)
GF Value™: ¥9.70 vs. price of ¥10.90 (12.4% above fair value)
Industry Position: 69.1% below the Medical Distribution median (#109 of 115)
No single metric tells the full story. See the SHSE:600739 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Liaoning Chengda Co Ltd is engaged in the business of pharmaceutical and medical, domestic and foreign trade, financial investment, and energy development. The trading division is engaged in the trading of textiles and clothing, steel, wood, and aquatic products. The company is also involved in securities, insurance, and fund business through its financial investment division.
54GF Score
Get the complete analysis for SHSE:600739
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600739 has been successfully added to your 
